BRIACELL THERAPEUTICS CORP. Long-Lived Assets
BRIACELL THERAPEUTICS CORP. (BCTX) had Long-Lived Assets of $215.07 thousand as of 2023-07-31, per its 10-K filed 2023-10-25.
Discontinued › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2023-10-25
- 2023-07-31: Long-Lived Assets $215.07K.
- 2022-07-31: Long-Lived Assets $230.34K; Long-Lived Assets as first filed $230.34K.
- 2021-07-31: Long-Lived Assets $245.61K.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2023-07-31 | $215.07K 10-K · filed 2023-10-25 | |
| 2022-07-31 | $230.34K 10-K · filed 2023-10-25 | $230.34K 10-K · filed 2022-10-28 |
| 2021-07-31 | $245.61K 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |